10 Best Stocks Under $10 Offering More Than 50% Upside
Despite war-related risks to consumer spending and inflation, SCFR remains optimistic about the broader U.S. economy and the stock market.
Wave Life Sciences Inc. (WVE)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | RA Capital Management Peter Kolchinsky | 26,975,505 | $156,727,684 | 1.36% | |
| 2. | Maverick Capital Lee Ainslie | 10,278,115 | $59,715,848 | +2% | 0.53% |
| 3. | Driehaus Capital Richard Driehaus | 5,443,143 | $31,624,661 | +1% | 0.18% |
| 4. | 683 Capital Partners Ari Zweiman | 4,950,000 | $28,759,500 | +2% | 1.41% |
| 5. | M28 Capital Marc Elia | 4,588,284 | $26,657,930 | 56.53% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $6.50 | 971,091 | $6,312,091.50 | 26,975,505 | 2026-03-30 | Filing | |
| $6.43 | 2,495,623 | $16,046,855.89 | 26,004,414 | 2026-03-27 | Filing | |
| $6.38 | 351,224 | $2,240,809.12 | 23,508,791 | 2026-03-26 | Filing | |
| $6.06 | 4,954,558 | $30,024,621.48 | 23,157,567 | 2026-03-26 | Filing | |
| $19.00 | 1,470,000 | $27,930,000.00 | 18,245,691 | 2025-12-11 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $6.01 | 7,000 | $42,070.00 | 44,930 | 2026-08-11 | Filing | |
| $5.29 | 12,700 | $67,183.00 | 0 | 2026-08-12 | Filing | |
| $6.01 | 3,864 | $23,222.64 | 20,079 | 2026-08-11 | Filing | |
| $6.01 | 432 | $2,596.32 | 24,968 | 2026-08-11 | Filing | |
| $15.00 | 15,294 | $229,410.00 | 61,867 | 2026-02-26 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 19,202,461 | $111,566,297 | 0% | |
| 2. | 18,245,691 | $106,007,465 | 17.6% | |
| 3. | 5,354,622 | $31,110,354 | 0.02% | |
| 4. | 4,922,477 | $28,599,589 | 0% | |
| 5. | 4,839,317 | $28,116,432 | 0% |
News See All
Is Wave Life Sciences Ltd. (WVE) A Good Stock To Buy Now?
Is WVE a good stock to buy? We came across a bullish thesis on Wave Life Sciences Ltd. on Biotech Distilled’s Substack. In this article, we will summarize the bulls’ thesis on WVE.
Billionaire Lee Ainslie's 10 Stocks with Huge Upside Potential
There is more greed than fear, going by the blockbuster gains in the equity markets following the US-Iran war-triggered correction in March.
Wave Life Sciences Ltd. (NASDAQ:WVE) Q1 2026 Earnings Call Transcript
Operator: Hello, and welcome to Wave Life Sciences First Quarter 2026 Earnings Call. [Operator Instructions]. Also, as a reminder, this conference call is being recorded today.
10 Best Small-Cap Biotech Stocks to Buy According to Hedge Funds
On February 16, Franklin Equity said the biotechnology industry has entered 2026 on a firmer footing following an extended period of market uncertainty in the prior year, noting that market attention ...
H.C. Wainwright Highlight Misread Risk in Wave Life Sciences Ltd. (WVE) Clinical Data Reaction
TheFly reported on April 14 that H.C. Wainwright reduced its price target on WVE from $30 to $18 while maintaining a Buy rating.
8 Oversold Biotech Stocks to Invest In Now
On February 5, J.P. Morgan revealed major themes that are expected to affect healthcare in 2026, emphasizing a resurgence of interest in the biopharma sector.
8 Healthcare Stocks Insiders Are Buying
Insider buying tends to draw attention because insiders know their companies best.
Wave Life Sciences Ltd. (WVE) PT Increased to $52 at Canaccord Following Pipeline Review
TheFly reported earlier on March 10 that Canaccord Genuity raised its price target for WVE to $52 from $43 while keeping a Buy rating on the stock.
13 Best Stocks to Invest In on Robinhood for Beginners
MacroMicro reports that as of March 18, 2026, the S&P 500's forward 12-month P/E was 21.35, which was far higher than its 10-year historical average of 18.9 but slightly lower than the 22.0x reported ...